Olainfarm First Quarter 2014 Investor Conference Webinar

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Olainfarm First Quarter 2014 Investor Conference Webinar

Olaine, June 5, 2014, 2014-06-05 15:00 CEST (GLOBE NEWSWIRE) -- Webinar will be hosted by the member of the management board Salvis Lapiņš. The presentation will be in English.

During the webinar Salvis Lapiņš will inform about AS “Olainfarm” latest activities and analyse the financial results of the first quarter 2014.

During the webinar the enclosed presentation will be presented.

What is webinar? Webinar is a virtual conference, during which company’s representative gives information about the company and its future plans. Webinar allows interactive communication and a possibility to ask questions and get answers directly from the company.

How to join the webinar? To join the webinar, please go to the site http://ej.uz/OLF_1Q_2014 on June 5, 2014 at 16:00, choose „Enter as a guest", type in your name, surname and click „enter”. You will be then directed to the webinar screen. Prior registration is not necessary.

Additional information on the webinar All you need to have is a computer with internet connection and headphones. No additional installations of special programs are necessary. You will be able to ask questions in writing or just listen to the host of webinar.

  Join the webinar and be the first one to hear the news!

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.   

         Information prepared by:          Salvis Lapins          JSC “Olainfarm”          Member of the Management Board          Rupnicu iela 5, Olaine, Latvia, LV 2114          Phone: +371 6 7013 717          Fax: +371 6 7013 777          e-mail: slapinsh@olainfarm.lv

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insights from the New First Presidency on Global Challenges

Updated Category News Views 218

A Historic Conversation with the First Presidency The recent interview featuring the new First Presidency of The Church of Jesus Christ of Latter-day Saints marks an exciting milestone. Conducted by the talented Jane Clayson Johnson, this unique dialogue sheds light on pressing issues within the Church and broader society. It was their first public discussion, making it a...

Continue Reading
Major Bets on Donald Trump's Election Surge Past $52 Million

Updated Category News Views 119

Significant Bets on Trump's Electoral Success A trader on Polymarket, operating under the alias Fredi9999, alongside four other accounts, has made headlines recently by placing enormous bets on Donald Trump’s electoral prospects. This activity has generated considerable chatter among traders in the market. Tracking Trump's Betting Activity Harry Crane, a statistics...

Continue Reading
FMC Corporation Faces Lawsuit Over Securities Violations

Updated Category News Views 190

FMC Corporation Faces Lawsuit Over Securities Violations Recently, the Gross Law Firm has alerted shareholders of FMC Corporation (NYSE: FMC) regarding significant legal developments. This lawsuit brings attention to serious allegations concerning the company's conduct during a specific class period. Shareholder Engagement and Participation Shareholders who purchased FMC...

Continue Reading
Insider Buying at Optima Health Signals Confidence in Future Growth

Updated Category News Views 132

Insightful Insider Share Purchase at Optima Health Optima Health plc (AIM: OPT), a leading provider of corporate health and wellbeing solutions in the UK, recently announced an important transaction involving one of its key insiders. Joanne Newey, who takes on the role of Group Business Development & Propositions Director and is also a Person Discharging Managerial...

Continue Reading
Outlook Therapeutics Prepares for Upcoming Investor Interaction

Updated Category News Views 78

Outlook Therapeutics Connects with Investors at Upcoming Virtual Event ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK) has been making waves in the biopharmaceutical field with its groundbreaking ocular therapy. This marks an exciting era for the company following the recent approval of its eye treatment formulation of bevacizumab, which targets wet age-related...

Continue Reading